Fortress Biotech, Inc.
FBIO
$2.29
$0.073.15%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 114.82% | 108.22% | 63.80% | 24.49% | 24.14% |
| Total Depreciation and Amortization | 4.41% | 2.16% | -7.05% | -6.04% | -25.56% |
| Total Amortization of Deferred Charges | -31.65% | -39.66% | -43.28% | -41.94% | -32.26% |
| Total Other Non-Cash Items | -64.37% | -40.40% | -18.54% | 55.29% | 49.16% |
| Change in Net Operating Assets | -208.80% | 2.55% | 9.33% | -29.02% | 35.08% |
| Cash from Operations | 17.97% | 35.30% | 19.05% | 32.63% | 37.46% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -80.58% | -80.58% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -42,757.14% | -1,349.28% | -393.42% | -86.57% |
| Cash from Investing | 167.47% | -7,644.44% | -256.99% | -577.56% | -613.27% |
| Total Debt Issued | -- | -90.60% | 98.01% | 200.57% | 2.68% |
| Total Debt Repaid | 44.00% | -158.43% | 82.81% | 96.55% | 98.48% |
| Issuance of Common Stock | -82.19% | -86.32% | -56.00% | -45.17% | -10.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | 33.75% | 33.75% | 62.50% | -- |
| Total Dividends Paid | -- | 100.00% | 100.00% | 75.00% | 50.00% |
| Other Financing Activities | 643.59% | 691.30% | -35.37% | -33.14% | -82.17% |
| Cash from Financing | 9.63% | 10.27% | 2.56% | 147.13% | 115.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 188.74% | 291.79% | 75.72% | 109.73% | 74.84% |